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In the reported clinical trials of human fetal
ventral mesencephalic transplants to the brain of
Parkinson patients the tissue was transplanted
either as small solid pieces or as cell suspensions.
In all cases the tissues were implanted immedi-
ately after explantation. Delayed surgery and the
in vitro maintenance of the tissue prior to trans-
plantation would present several advantages.
For example, this would allow one to estimate
the approximate number of neurons trans-
planted and to measure dopamine content and
tyrosine-hydroxylase (TH) activity in vitro
expressing the activity of the cultures. Further-
more tissues in vitro could be treated with
various growth factors.
Here we present a protocol to maintain
human fetal ventral mesencephalic tissue in free
floating microcultures. Ventral mesencephalon
of human fetuses was obtained from material of
induced suction abortions. Out of 38 abortions
the mesencephalon could be identified in 16
cases (50% in fetuses age 8-10 weeks post mens.
and 31% in fetuses age 11-13 weeks post mens.)
based on macroscopic criteria. The landmarks
which allowed identification were first the isth-
mus rhombencephali and second the IV ventri-
cle (caudal to the mesencephalon) and the
recessus ventriculi III (rostral to the mesen-
cephalon) as well as the mesencephalic flexure.
However the tissue was most often fractured at
the isthmus.
The ventral mesencephalon was dissected out
of the identified brain tissue and divided into
four longitudinal pieces. These pieces were
transversely chopped in 250m steps by means
of a tissue chopper (McIllwain). These tissue
pieces (one piece per tube) were transferred
into plastic tubes (Falcon No. 2095) (one culture
per tube) containing 1 ml of medium. One hun-
dred ml of medium consisted of 55 ml Dulbecco
MEM (Gibco No. 041-02320), 32.5 ml Hanks
BSS (Gibco No. 041-04020), 1.5 ml glucose 20%,
10 ml FCS (Gibco No. 013-06290), and 1 ml of
23.8% HEPES. A triple-antibiotic (Gibco No.
043-05240D) was used during the first 4 days in
vitro. Ten ng/ml NGF, 10 ng/ml BDNF or 10
ng/ml bFGF was added to the medium. The
tubes were placed in a revolving drum (60
revolutions per hour) in an incubator with 5%
COz. The medium was changed at 3 and 4 day
intervals. After 5-14 days in vitro, these cultures
were pooled in groups of 5-10 cultures and pro-
cessed for electron microscopy, histology in
frozen sections or enzyme and transmitter
assays.
The cultures survived and developed further
in vitro. After 5 days in vitro, the tissue pieces
had turned into small round balls of 0.5 to 1 mm
in diameter. Histological examinations of mes-
encephalic cultures showed good survival of the
tissue. TH positive cells were demonstrated by
immunohistochemistry and dopamine and tyro-
sine hydroxylase was detected in biochemical
assays. When free floating microcultures were
explanted onto coverslips after 14 days in vitro
and grown by the roller tube method for one
week, newly formed processes extended from
the explant.
These experiments show the feasibility of
maintaining human fetal ventral mesencephalon
in vitro by means of free floating microcultures.
It is suggested that the transplantation of these
cultures be tested in rats as a next step.
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